Gaps Pharmaceutical Limited - Company Profile

It is a pharma public limited company based in Dausa, Rajasthan, India, established in 2023.
2023 Dausa, Rajasthan, India Active
Last Updated:
Access Report
About Gaps Pharmaceutical Limited

Gaps Pharmaceutical Limited, a active public limited company, was established on 16 May 2023 in Dausa, Rajasthan, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U47721RJ2023PLC087693. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ashok Kumar Upadhyaya (Director), Pawan Kumar Sharma (Director), Suneet Kumar Upadhyaya (Director). Past directors included Gayatri Upadhyay, Gyan Chand Sharma. It is based at Anand Hospital, Nh-11 A, Kothun Road, Dausa, Rajasthan, 303503.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721RJ2023PLC087693

  • Registration Number

    087693

  • Incorporation Date

    16 May 2023

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 28 Days
Company report

Gaps Pharmaceutical Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Gaps Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gaps Pharmaceutical Limited?
Current Directors
Name Designation Appointment Date Status
Ashok Kumar Upadhyaya Director 16 May 2023 Current
Pawan Kumar Sharma Director 16 May 2023 Current
Suneet Kumar Upadhyaya Director 16 May 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gaps Pharmaceutical.

Enhance accessibility to Gaps Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gaps Pharmaceutical revenue growth over time
Gaps Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gaps Pharmaceutical?

Unlock access to Gaps Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gaps Pharmaceutical?

Unlock and access historical data on people associated with Gaps Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gaps Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gaps Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gaps Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Progress on Ashok Kumar Upadhyaya was appointed as a Director was appointed as a Director on 16 May 2023 & has been associated with this company since 3 years 28 days . was documented.

  • Director Appointment

    Pawan Kumar Sharma was appointed as a Director was appointed as a Director on 16 May 2023 & has been associated with this company since 3 years 28 days . was recorded as a recent event.

  • Director Appointment

    Progress on Suneet Kumar Upadhyaya was appointed as a Director was appointed as a Director on 16 May 2023 & has been associated with this company since 3 years 28 days . was documented.

  • Company Incorporation

    The activity Gaps Pharmaceutical Limited was registered on 16 May 2023 with Roc Jaipur & aged 3 years 28 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gaps Pharmaceutical Limited?

The CIN of Gaps Pharmaceutical Limited is U47721RJ2023PLC087693.

Where is Gaps Pharmaceutical Limited headquartered?

Gaps Pharmaceutical Limited is headquartered at Anand Hospital, Nh-11 A, Kothun Road, Dausa, Rajasthan, 303503.

When was Gaps Pharmaceutical Limited incorporated?

Gaps Pharmaceutical Limited was incorporated on 16 May 2023.

Who are the current directors of Gaps Pharmaceutical Limited?

The current directors of Gaps Pharmaceutical Limited are

What is the primary industry of Gaps Pharmaceutical Limited?

The primary industry of Gaps Pharmaceutical Limited is Pharma.

Is Gaps Pharmaceutical Limited a listed company?

Gaps Pharmaceutical Limited is unlisted.

What is the capital structure of Gaps Pharmaceutical Limited?

The authorized capital of Gaps Pharmaceutical Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available